ID: ALA336069

Max Phase: Preclinical

Molecular Formula: C16H13NO5

Molecular Weight: 299.28

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Oc1cc2cc(O)c(O)cc2c(Cc2ccc(O)c(O)c2)n1

Standard InChI:  InChI=1S/C16H13NO5/c18-12-2-1-8(4-13(12)19)3-11-10-7-15(21)14(20)5-9(10)6-16(22)17-11/h1-2,4-7,18-21H,3H2,(H,17,22)

Standard InChI Key:  OZKHVCSGRBQRGG-UHFFFAOYSA-N

Associated Targets(Human)

Insulin-like growth factor binding protein 3 46 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 299.28Molecular Weight (Monoisotopic): 299.0794AlogP: 2.35#Rotatable Bonds: 2
Polar Surface Area: 114.04Molecular Species: NEUTRALHBA: 6HBD: 5
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.28CX Basic pKa: 0.76CX LogP: 2.79CX LogD: 2.73
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.46Np Likeness Score: 0.39

References

1. Chen C, Zhu YF, Liu XJ, Lu ZX, Xie Q, Ling N..  (2001)  Discovery of a series of nonpeptide small molecules that inhibit the binding of insulin-like growth factor (IGF) to IGF-binding proteins.,  44  (23): [PMID:11689087] [10.1021/jm010304b]

Source